March 9, 2021 Experience Nurix Therapeutics $160.4 million follow-on offering We advised the underwriters on the equity offering
March 1, 2021 Experience Adamas Pharmaceuticals $59 million stock offering We advised the joint book-running managers on the SEC-registered equity offering
February 22, 2021 Experience Chegg $1.15 billion stock offering We advised the joint book-running managers on the SEC-registered equity offering
February 22, 2021 Experience Lucid Motors $24 billion combination with Churchill Capital Corp IV We are advising Lucid Motors on its combination with a SPAC
February 18, 2021 Experience Crowdstrike $400 million acquisition of Humio We are advising Crowdstrike on the acquisition
January 28, 2021 Experience Sunrun $400 million convertible senior notes offering We advised the initial purchasers on the Rule 144A offering
January 20, 2021 Experience CrowdStrike Holdings $750 million bond offering We advised CrowdStrike on the SEC-registered offering
January 19, 2021 Experience Poshmark $318.8 million IPO The shares are listed on the Nasdaq Global Select Market
January 15, 2021 Experience Affirm Holdings $1.39 billion IPO The shares are listed on the Nasdaq Global Select Market
December 11, 2020 Experience Atara Biotherapeutics $175 million common stock and pre-funded warrants offering Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $175 million SEC-registered common stock and pre-funded warrants…